![]() ![]() Beckman Coulter has been a trusted partner for Lenco in the provision of a full range of diagnostic services including chemistry, immunoassay, hematology, and urinalysis. “Lenco has been a leading provider of clinical laboratory services to residents of Brooklyn, NYC, and the tristate metropolitan area with the highest number of positive COVID-19 cases in the country. Robert Boorstein, M.D., Ph.D, Medical Director, Lenco Diagnostics Laboratory, added: Prior to offering the Beckman Coulter SARS-CoV-2 IgG antibody test to patients, Lenco conducted its own independent verification of the performance of the assay and are highly satisfied with the quality of the results. We’re proud to be part of the solution that is helping to drive the recovery in New York and around the world.” Because of the high COVID-19 prevalence rate in New York City, the need to launch a high quality assay that has greater than 99% positive predictive value is critical. We have worked tirelessly to develop what I believe is the highest quality serology test on the market, and we are excited to announce the shipment of 40,000 of these tests to Lenco Labs. Because of this, New York has been top of mind for our new SARS-CoV-2 IgG serology test. “New York has been at the epicenter of a medical crisis unlike anything we have experienced in our country since the 1918 influenza epidemic. MPH, Chief Medical Officer, Beckman Coulter, added: ![]() That’s why I’ve been proud to work closely with Brooklyn’s own Lenco Labs and applaud their partnership with Beckman Coulter to be the first to bring these high-quality antibody tests to New York City.” “While we’re making progress in our fight against the coronavirus, there’s no path to re-opening our communities without quality, accurate and extensive testing. The company is able to deliver more than 30 million tests per month.Ĭongressman Max Rose (D-Brooklyn) applauded the boost in new testing resources, stating: The assay has been rigorously validated against more than 1,400 negative broad-based population samples to ensure the test is specific to SARS-Cov-2. The Beckman Coulter COVID-19 serology test is one of the most accurate and high-quality tests available in the U.S., and has 100% Positive Percent Agreement (sensitivity) and a confirmed 99.6% Negative Percent Agreement (specificity). Lenco was among the first clinical labs to receive a shipment of the new Beckman Coulter SARS-CoV-2 IgG antibody test. Serology test has confirmed 100% sensitivity and 99.6% specificityīrooklyn, New York, JBeckman Coulter and Lenco Diagnostic Laboratories (Lenco), one of NYC's largest privately-owned full-service reference laboratories, today announced that the first shipment of 40,000 of Beckman Coulter’s new Access SARS-CoV-2 IgG Antibody tests has arrived in New York City to help battle the COVID-19 outbreak, with 20,000 additional tests anticipated each week. ![]() 40,000 of Beckman Coulter’s new Access SARS-CoV-2 IgG Antibody tests already received by New York City through Lenco LabsĬongressman Max Rose and Brooklyn Borough President Eric Adams praise increase in high quality testing resources to help New York City and State ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |